Ezeh Peace C, Xu Huan, Wang Shu Chun, Medina Sebastian, Burchiel Scott W
Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona.
College of Pharmacy, Department of Pharmaceutical Sciences, University of New Mexico, Albuquerque, New Mexico.
Curr Protoc Toxicol. 2016 Feb 1;67:18.9.1-18.9.12. doi: 10.1002/0471140856.tx1809s67.
Development of blood cells through hematopoiesis occurs in the bone marrow (BM), and can be adversely impacted by various substances and/or conditions ranging from known therapeutic, intentionally administered xenobiotics to unintentional food additives and exposure to environmental chemicals. The principles underlying the techniques for evaluating toxicity to BM progenitors (erythroid, myeloid, and lymphoid) exploit changes in the normal hematopoietic process, biochemical cell surface and intracellular markers, as well as components of the BM microenvironment. Toxicological investigations following in vivo exposures of mice or in vitro exposures of mouse primary BM cell cultures allow the assessment of the developmental and functional integrity of BM cells, cell population shifts, and adverse biochemical effects due to toxicity. Colony forming unit (CFU) assays and flow cytometry are indispensable techniques in these toxicity studies.
血细胞通过造血作用在骨髓中发育,可能受到各种物质和/或条件的不利影响,这些物质和条件范围广泛,从已知的治疗性、有意施用的异生物素到无意的食品添加剂以及环境化学物质暴露。评估对骨髓祖细胞(红细胞、髓细胞和淋巴细胞)毒性的技术所依据的原理利用了正常造血过程、生化细胞表面和细胞内标志物以及骨髓微环境成分的变化。对小鼠进行体内暴露或对小鼠原代骨髓细胞培养物进行体外暴露后的毒理学研究,能够评估骨髓细胞的发育和功能完整性、细胞群体变化以及毒性导致的不良生化效应。集落形成单位(CFU)测定和流式细胞术是这些毒性研究中不可或缺的技术。